|
|
 |
-
Use of ActicoatTM
in Difficult to Heal and Chronic Wounds
-
Overview
There are several types of wounds which
characteristically are much more difficult to
heal than the acute traumatic wounds. The major
reasons are the typical presence of impaired
perfusion as seen, e.g. with venous hypertension
or diabetes and an underlying disorder such as
immobility as seen in the population with
pressure ulcers.
Typically, these wounds begin healing by the
normal acute healing process with the
process simply being prolonged into months
instead of weeks. There is also an increased
risk of wound complications due to the
underlying impediments to healing. These wounds
are also at high risk for evolving into a
chronic wound, which fit into the difficult to
heal category are a diabetic, venous stasis and
pressure ulcer.
Difficult to heal wounds:
-
Diabetic Ulcer
-
Venous Stasis Ulcer
-
Pressure Ulcer
Each have distinct properties which make them
difficult to heal. All of them share the
characteristics of impaired perfusion and
increased risk of infection, increased bacterial
burden and inflammation.
Chronic wounds differ substantially from an
acute wound. The wound no longer follows the
normal healing processes. The term “non-healing
wound” is often used to describe the chronic
wound. Characteristics are presented. However,
the exact distinction between acute and chronic
is still somewhat arbitrary and often based on
the cause of the wound and physical status of
the patient.
|
|
Chronic Wound Characteristics |
-
Wound which fails the normal
healing process
-
Lack of any significant
healing over a 3 month period despite good
local care
-
Excess wound inflammation is
present
-
Wound surface often contains
necrotic tissue and increased exudates
-
Colonization with bacteria is
usually present
-
Increased levels of wound
metalloproteases which can damage any new
tissue formation
-
Decreased protease inhibitors
-
Decreased surface growth
factors
|
The time period most commonly used to define a
chronic wound is usually
3 months
of lack of healing. The most common chronic
wounds are pressure ulcers, diabetic ulcers and
venous stasis ulcers. The 3 categories account
for 70% of chronic wounds. However, any acute
wound, which fails to follow the normal healing
process can become a chronic wound. It is
important that criteria for determining when an
acute wound becomes a chronic wound be met
before calling a wound “chronic”. For example, a
pressure ulcer characteristically heals slower
than an acute surgical wound but a pressure
ulcer can progressively heal by the normal
healing process. It only becomes a chronic wound
if there is failure of the normal healing
process. Successful treatment of the chronic
wound depends on a thorough understanding of the
pathophysiologic mechanisms underlying the
failure of the normal wound healing process.
|
|
Common Types of Chronic Wounds |
|
□ Pressure
Ulcers
□ Vascular
Insufficiency: Chronic Venous Hypertension,
Arterial Insufficiency
□ Metabolic:
Diabetes Mellitus, Gout
□ Infection:
Vasculitis
□ Malignant
Cutaneous Wounds
□ Radiation
Burns |
|
These wounds cause a major disability due to the
chronicity and frequent recurrence and therefore
negatively impact quality of life in addition to
producing an enormous health care cost
(3billion/yr in the U.S.). |
-
Etiology
A number of etiologic factors have been
identified which impede the normal healing
process allowing a chronic wound to develop.
Systemic factors such as malnutrition and
chronic illness prevent the acute wound from
healing due to inadequate protein synthesis
needed for new tissue development. Other factors
such as impaired perfusion, hypoxia, do not
allow healing to occur because of inadequate
oxygen. Other systemic factors such as
infection, diabetes and corticosteroids directly
impede healing.
The most common local factors which allow a
chronic wound to develop are continued
mechanical trauma to the wound and/or the use of
wound care products toxic to the cells of the
wound bed. Repeated loss of the new tissue
synthesis will eventually lead to a chronically
inflamed wound.
|
|
Etiologic Factors Leading to Chronic Wounds |
-
Malnutrition
(protein-calorie) especially with
involuntary weight loss
-
Micronutrient deficiency
-
Tissue hypoxia
-
Infection
-
Diabetes Mellitus
-
Chronic disability: elderly,
chronic disease
-
Use of toxic wound care
products
-
Inadequate care of the acute
wound
-
Mechanical Injury
(repetitive): pressure, shear force,
friction
-
Radiation Therapy
|
-
Treatment of the Difficult to Heal and
Chronic Wounds with ActicoatTM
There is increasing evidence that
nanocrystalline silver Acticoattm
is very effective in the management of difficult
to heal and chronic wounds.
|
|
Difficult to Heal
& Chronic
Wounds |
-
Sibbald R. Screening
evaluation of an ionized nanocrystalline
silver dressing in chronic wound care.
Ostomy Wound Management 2001:47;38.
-
Dousett C. An overview of
Acticoattm dressing in wound management.
Br. J Nurs 2003:12;44
-
Fromantin I. Use of
nanocrystalline silver in cancer wounds.
Soins 2003:678;31
|
|
The nanocrystalline silver is very effective at:
-
Decreasing bacterial burden
-
Controlling excess inflammation
-
Deceasing
-
Maintaining
moist healing environment
|
|
|
|
Chronic Wound |
 |
|
Management of Difficult to heal
ulcers with a new silver dressing: A clinical
evaluation.
(Poster presentation, EWMA, Grenada, 2002) Romanelli M, et al (Dept
Dermatology, University Hospital of Pisa, Italy) |
|
Venous Leg Ulcer |
|
|
 |
Introduction
The process of healing is an overlapping,
interconnected process, where there is active
interaction between the cellular components and
the extra-cellular matrix. All play an active
role in the process of healing and inflammation.
The slightest disruption to the proper
functioning of any one of these overlapping
chain-like processes may impede/delay healing
resulting in a pathological/chronic wound.
|
|
Treated with Acticoat, results
after 4 weeks. |
 |
|
Venous Leg Ulcer |
|
 |
 |
|
Treated with Acticoat, results after 4 weeks. |
|
Case
Study: |
The Use of
Acticoat on an infected thigh stump
(EVEAN Thiuszorg,
Wondevrepleegkundige, Netherlands)
|
|
An infected thigh stump in a
patient with vascular disease |
 |
 |
|
Infected amputation site with
massive fat necrosis. |
Wound dressed with Acticoat and
covered with an absorbent secondary dressing. |
| |
 |
 |
|
Heavily exuding wound during
first few days. |
At 7 days P. aeruginosa, S.
aureus, and Streptococci colonization was
reduced. After 12 days wound swabs were clear.
Wound healed in 7 weeks. |
|
Case
Study: |
|
The use of
Acticoattm/
Acticoattm
7 on infected ulcers of the foot and lower leg
(Dr. Huuk, Kath. Krankenhaus gem.
GmbH (Catholic Hospital, non-profit limited
company) Dr. Winkelhoff, Head of the hospital
surgical department. St.Johnnes-Hospital) |
|
Infected ulcers on the anterior and posterior
aspects of both legs. |
|
 |
 |
|
Infected ulcers on the anterior and posterior
aspects of both legs. |
|
 |
 |
 |
-
Treatment with Acticoattm
-
Acticoattm
used in conjunction with a secondary
dressing
-
Acticoattm
and secondary dressing are under the
compression dressing
|
|
 |
 |
|
After 64 days the ulcers had clearly improved
with treatment. |
|
Case
Study: |
|
The use of
Acticoattm 7 on an acutely infected
leg ulcer (Stephen
Cook, Tissue Viability Nurse, The Queen
Elizabeth Hospital, Norfolk, UK) |
| |
 |
Patient was an 82 year old admitted with a
fracture of the left distal femur, suspected DVT
(deep vein thrombosis) and cellulitis. Pictured
is his extremely inflamed and painful right leg. |
 |
On exam, infection was seen tracking up the leg.
Systemic antibiotics were begun, and Acticoattm
7 was used to dress the wound. The wound had
greatly improved by day 7 and the patient was
now pain free. Some over-granulation was noted,
Acticoattm
7 treatment continued in combination with a
secondary pressure dressing. |
 |
The over-granulation was stopped
and the wound had healed by 95%. The combined
effect of systemic antibiotics and
Acticoattm
7 had a dramatic effect on the ulcer by
controlling infection and improving healing.
|
-
Diabetic Ulcers
|
Incidence:
Approximately 15-20% of
the estimated 16 million diabetics in the United
States will be hospitalized for a foot
complication, usually an ulcer, during the
course of their disease. Progression of these
ulcers are the leading cause of foot
amputations.
|
Characteristics:
The ulcer is usually full thickness, therefore
extra-cellular matrix components are initially
absent. The most common site is on the foot,
especially over bony prominences and on the
heel. The ulcers are typically full thickness
and difficult to heal, often becoming chronic
wounds. An adequate description of ulcer
characteristics is necessary for selection of
appropriate treatment. Description includes
size, depth, appearance and location. In
addition, it must be determined whether the
ulcer is the result of neuropathy, ischemia or
typically both. Gentle probing with a blunt
sterile probe will detect the presence of an
undermining ulcer and the presence of sinus
tracts.
One classification system uses wound color as a
marker of wound status:
Red
wounds are usually the healthiest and need wound
coverage for protection and to maintain
moisture.
Yellow
wounds indicate the presence of non-viable but
moist tissue. Wounds need to be debrided to
remove necrotic tissue and reduce the bacterial
load. Frank infection does not need to be
present to retard healing, simply an increased
bacterial burden which overwhelms the wounds
defenses.
Black
wounds indicate dead, dehydrated tissue or
eschar on the wound surface. The eschar needs to
be removed to be able to assess the wound,
prevent infection and promote healing.
|
Treatment:
The primary goal of treatment is to obtain wound
closure. Treatment is multifaceted due to the
complex nature of the wound. Relief of
pressure on the ulcer is critical to
the wound healing process. This endpoint often
requires pressure relieving interventions. Total
contact casting reapplied weekly is the optimum
management of pressure off-loading. Treatment of
any underlying ischemia is required. Distal
vascular reconstruction may be required to
restore pulsatile flow to the foot. When
infection is present, appropriate aerobic and
anaerobic antibiotic therapy is necessary.
Adequate insulin availability to the wound is
needed to stimulate healing. Also, blood sugar
control is important for healing.
Debridement of all necrotic tissue and callous
is also required. Debridement should be
performed to bleeding tissue. Moist wound
healing should then be initiated along with
protection from external contamination.
Nanocrystalline silver (ActicoatTM)
should improve healing by:
-
Decreasing bacteria
-
Decreasing inflammation
-
Providing a moist healing environment
|
|
Treatment of Diabetic Ulcer |
-
Relief of pressure on the
ulcer
-
Correction of ischemia, if
possible
-
Debridement of necrotic
tissue
-
Control of bacterial burden
and infection
-
Maintain moist wound healing
-
Adequate insulin therapy,
control of blood glucose and increase
anabolic activity
-
Modulate excess inflammation
|
|
Generally infections can be detected by the
presence of surrounding cellulitis. Cultures
should be obtained from purulent drainage or
curetted material from the wound bed. Palpation
of foot pulses should be performed as well as
non-invasive Doppler blood flow studies.
Radiographs of extensive ulcers should be
performed to assess for underlying osteomyelitis. |
|
Evidence of Excessive
Bacterial Content:
-
Increased wound drainage
-
Increase in very friable granulation tissue
-
Increasing pain, edema, peri-wound redness
-
Wound not healing despite appropriate
optimum care
|
|
Case Study: |
|
The use of Acticoat on a diabetic
ulcer |
 |
Patient is an 80 year old
diabetic with an ulcer on his left heel present
for 1 year. Wound dimensions were 6cm wide, 7 cm
long and 1 cm deep. Note the periwound redness,
maceration and edema, with exudates and malordor. |
 |
The wound was covered with
Acticoattm
7
and an absorbent secondary dressing applied.
|
 |
After 4 weeks, the wound had
significantly reduced in size to 0.8cm wide,
3.7cm long and 0.2cm deep, a reduction of 93%.
The patient no longer experienced pain and the
wound was free of signs of infection. |
 |
The patient had approximately 12
months of conventional treatment for his
diabetic ulcer, and the ulcer remained unhealed,
at a cost of $14,500.00. A 4 piece course of
ActicoatTM 7 resulted in an ulcer reduced in size
within 4 weeks at a cost of $1,700.00. |
|
Conclusion: The nanocrystalline silver improved
healing while decreasing cost. |
-
Experience with ActicoatTM
in treating Venous Stasis Ulcer
|
Definition
& Etiology:
Venous stasis ulcer is a partial or full
thickness wound on the lower extremities often
over the malleolus caused by venous
insufficiency, local stasis, edema and resulting
ischemia. Venous ulcers occur when the
superficial leg veins become dilated from
inadequate valve function leading to stasis and
venous hypertension.
There are several theories as to the etiology
and the difficulty of healing:
-
Calf venous pump failure
-
Peri-capillary fibrin cuffs which impair
oxygen diffusion to the wound
-
Macromolecules like fibrinogen leak into the
dermis, due to venous hypertension, and trap
Growth Factors and Matrix Proteins making
them unavailable for the repair process.
-
Decrease in nutritive skin capillary blood
flow
-
Combination of the above
|
Incidence:
Venous ulcers account for over 70% of chronic
leg ulcers with the incidence increasing with
age. The prevalence in the adult population
either active or healed is about 1-2%.
|
Characteristics:
The classic presentation is an irregularly
shaped wound with well defined borders
surrounded by erythematous or hyper-pigmented
skin. A yellow to white exudates is commonly
observed. The lower leg is typically edematous.
Varicosities are often present, and a dilated
vein may be near the base of the ulcer. The
surrounding skin change is known as
lypodermatosclerosis. This process is caused by
chronic changes in the soft tissue from edema
and inflammation. The skin is often tender and
can be mistaken for infection.
|
|
Characteristics of Venous Ulcers |
-
Irregularly shaped wound with
well defined borders
-
Found on the lower leg often
over the medial malleolus
-
Yellowish exudates often at
base
-
Lower leg and foot edema
usually present
-
Surrounding skin brawny,
erythematous or hyper-pigmented
-
Lower leg venous hypertension
|
Treatment:
The treatment goals for venous ulcers are first
and foremost to decrease tissue edema with
compression therapy, followed by healing of the
ulcer, control of pain and prevention of
recurrence, the latter by controlling edema.
Local care to the ulcer includes optimizing the
healing environment. Initiation of moist wound
healing while minimizing infection risk, and
environmental insults is the standard of care.
Controlling excess inflammation and MMP would
also be very advantageous for healing. As with
any tissue ulcer, debridement of necrotic tissue
along with control of exudates is necessary. A
variety of hydrogels and alginates are used
including a nanocrystalline silver alginate, in
addition to the Acticoattm.
|
|
Treatment of Venous Ulcers |
-
Control of tissue edema with
compression therapy
-
Correction of any ischemia
-
Debridement of necrotic
tissue
-
Control infection
-
Maintain moist wound healing
-
Control inflammation
|
|
Case Study:
|
|
Patient is a 45 year old international
businessman with a non healing venous stasis
ulcer for 2 years, despite compression therapy.
Edema management was made difficult by
traveling. The ulcer was 4cm x 6cm prior to
treatment with Acticoat 7Ô
(Figure 1). Initial cultures grew 2+ staph
Aureus. He was then managed with Acticoat 7Ô
followed by a soft moist gauze, followed by
compression. The dressing was changed weekly
(Figure 70). |
|
Figure 69: |
Figure 70: |
 |
 |
|
The ulcer healed by 50% in 4 weeks and by 85% 8
weeks (Figure 71, 72). The ulcer was healed by 12
weeks. |
| |
Wound is 85% healed |
 |
 |
|
The use of ActicoatTM on a
venous leg ulcer present for 13 months (Kerrie
Coleman, Clinical Nurse Specialist, Outpatient
Services, Royal Brisbane Hospital, Australia) |
|
 |
The patient was 74 years old with
a longstanding history of leg ulceration and
deep venous disease. The ulcer was heavily
exuding, malodorous and composed of slough and
granulating tissue. |
|
 |
At day 6 the wound was responding
quickly to the treatment, which consisted of a
moistened. Acticoat 7Ô and a multi layer
compression bandage. Initially, the dressings
were change twice weekly for exudates
management. |
|
 |
Note continued improvement of the
ulcer, after 6 weeks. |
|
 |
The ulcer had improved further
and by 8 weeks the ulcers were close to healing.
|
TOC
[References]
|
|
|
| |